Outcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infection
2018 ◽
Vol Volume 11
◽
pp. 441-445
◽
Keyword(s):
2011 ◽
Vol 1
(1)
◽
pp. 15-18
2017 ◽
Vol 66
(1)
◽
pp. S728-S729
◽
2010 ◽
Vol 40
(1)
◽
pp. 29-38
◽
Keyword(s):
2018 ◽
Vol 04
(03)
◽
2011 ◽
Vol 71
(6)
◽
pp. 456-461
◽
Keyword(s):
2016 ◽
Vol 64
(2)
◽
pp. S769-S770
◽
Keyword(s):